Cargando…

HIV-1 neutralizing antibodies provide sterilizing immunity by blocking infection of the first cells

Neutralizing antibodies targeting HIV-1 Env have been shown to protect from systemic infection. To explore whether these antibodies can inhibit infection of the first cells, challenge viruses based on simian immunodeficiency virus (SIV) were developed that use HIV-1 Env for entry into target cells d...

Descripción completa

Detalles Bibliográficos
Autores principales:	Stab, Viktoria, Stahl-Hennig, Christiane, Ensser, Armin, Richel, Elie, Fraedrich, Kirsten, Sauermann, Ulrike, Tippler, Bettina, Klein, Florian, Burton, Dennis R., Tenbusch, Matthias, Überla, Klaus
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Elsevier 2023
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10591032/ https://www.ncbi.nlm.nih.gov/pubmed/37804829 http://dx.doi.org/10.1016/j.xcrm.2023.101201

Ejemplares similares

Characterization of SARS-CoV-2 Escape Mutants to a Pair of Neutralizing Antibodies Targeting the RBD and the NTD
por: Peter, Antonia Sophia, et al.
Publicado: (2022)

Protective Efficacy and Immunogenicity of a Combinatory DNA Vaccine against Influenza A Virus and the Respiratory Syncytial Virus
por: Stab, Viktoria, et al.
Publicado: (2013)

Coexpression of GM-CSF and antigen in DNA prime-adenoviral vector boost immunization enhances polyfunctional CD8+ T cell responses, whereas expression of GM-CSF antigen fusion protein induces autoimmunity
por: Tenbusch, Matthias, et al.
Publicado: (2008)

Immunogenicity of DNA Vaccines Encoding Simian Immunodeficiency Virus Antigen Targeted to Dendritic Cells in Rhesus Macaques
por: Tenbusch, Matthias, et al.
Publicado: (2012)

Enhancement of immunostimulatory properties of exosomal vaccines by incorporation of fusion-competent G protein of vesicular stomatitis virus
por: Temchura, Vladimir V., et al.
Publicado: (2008)

A pair of noncompeting neutralizing human monoclonal antibodies protecting from disease in a SARS‐CoV‐2 infection model
por: Peter, Antonia Sophia, et al.
Publicado: (2021)

Increased APOBEC3G and APOBEC3F expression is associated with low viral load and prolonged survival in simian immunodeficiency virus infected rhesus monkeys
por: Mußil, Bianka, et al.
Publicado: (2011)

Strong mucosal immune responses in SIV infected macaques contribute to viral control and preserved CD4+ T-cell levels in blood and mucosal tissues
por: Schultheiss, Tina, et al.
Publicado: (2011)

Methodological Development of a Multi-Readout Assay for the Assessment of Antiviral Drugs against SARS-CoV-2
por: Hahn, Friedrich, et al.
Publicado: (2021)

Effect of semen and seminal amyloid on vaginal transmission of simian immunodeficiency virus
por: Münch, Jan, et al.
Publicado: (2013)

Elevated granzyme B(+) B-cell level in SIV-infection correlate with viral load and low CD4 T-cell count
por: Kotb, Ahmad, et al.
Publicado: (2017)

Smaller, Stronger, More Stable: Peptide Variants of a SARS-CoV-2 Neutralizing Miniprotein
por: Weißenborn, Lucas, et al.
Publicado: (2022)

In vitro SIV replication kinetics correlate with vaccine induced cellular immune responses and predict post-challenge outcome in immunized rhesus macaques
por: Ochieng, Washingtone, et al.
Publicado: (2006)

Host factors determine differential disease progression after infection with nef-deleted simian immunodeficiency virus
por: Sopper, Sieghart, et al.
Publicado: (2014)

Divergence of Primary Cognate B- and T-Cell Proliferative Responses to Subcutaneous and Intravenous Immunization with Virus-Like Particles
por: Temchura, Vladimir, et al.
Publicado: (2014)

Pre-infection transcript levels of FAM26F in peripheral blood mononuclear cells inform about overall plasma viral load in acute and post-acute phase after simian immunodeficiency virus infection
por: Javed, Aneela, et al.
Publicado: (2016)

Protective mucosal immunity against SARS-CoV-2 after heterologous systemic prime-mucosal boost immunization
por: Lapuente, Dennis, et al.
Publicado: (2021)

Revisiting a quarter of a century of simian immunodeficiency virus (SIV)-associated cardiovascular diseases at the German Primate Center
por: Mietsch, Matthias, et al.
Publicado: (2017)

Cloning of a Passage-Free SARS-CoV-2 Genome and Mutagenesis Using Red Recombination
por: Herrmann, Alexandra, et al.
Publicado: (2021)

Antigen-dependent modulation of immune responses to antigen-Fc fusion proteins by Fc-effector functions
por: Richel, Elie, et al.
Publicado: (2023)

Innate signalling molecules as genetic adjuvants do not alter the efficacy of a DNA-based influenza A vaccine
por: Lapuente, Dennis, et al.
Publicado: (2020)

Antibodies Targeting KSHV gH/gL Reveal Distinct Neutralization Mechanisms
por: Fricke, Thomas, et al.
Publicado: (2022)

Inhibition of early steps in the lentiviral replication cycle by cathelicidin host defense peptides
por: Steinstraesser, Lars, et al.
Publicado: (2005)

The HIV 5′ Gag Region Displays a Specific Nucleotide Bias Regulating Viral Splicing and Infectivity
por: Grewe, Bastian, et al.
Publicado: (2021)

Rapid response flow cytometric assay for the detection of antibody responses to SARS-CoV-2
por: Lapuente, Dennis, et al.
Publicado: (2020)

T cell independent secondary antibody responses to the envelope protein of simian immunodeficiency virus
por: Nabi, Ghulam, et al.
Publicado: (2012)

Selection of a T7 promoter mutant with enhanced in vitro activity by a novel multi-copy bead display approach for in vitro evolution
por: Paul, Siddhartha, et al.
Publicado: (2013)

P04-32. Differential regulation of secondary antibody responses to Gag and Env proteins
por: Nabi, G, et al.
Publicado: (2009)

Propagation of SARS-CoV-2 in a Closed Cell Culture Device: Potential GMP Compatible Production Platform for Live-Attenuated Vaccine Candidates under BSL-3 Conditions?
por: Klessing, Stephan, et al.
Publicado: (2023)

SARS-CoV-2 and SARS-CoV Spike-Mediated Cell-Cell Fusion Differ in Their Requirements for Receptor Expression and Proteolytic Activation
por: Hörnich, Bojan F., et al.
Publicado: (2021)

Genome Sequence of the Alcelaphine Gammaherpesvirus 1 Attenuated Laboratory Strain WC11
por: Ensser, Armin
Publicado: (2017)

Vector-based antiviral therapy
por: Ensser, Armin
Publicado: (2006)

Novel Trypanocidal Inhibitors that Block Glycosome Biogenesis by Targeting PEX3–PEX19 Interaction
por: Li, Mengqiao, et al.
Publicado: (2021)

Inhibitors of Deubiquitinating Enzymes Block HIV-1 Replication and Augment the Presentation of Gag-Derived MHC-I Epitopes
por: Setz, Christian, et al.
Publicado: (2017)

Exclusive Decoration of Simian Immunodeficiency Virus Env with High-Mannose Type N-Glycans Is Not Compatible with Mucosal Transmission in Rhesus Macaques
por: Karsten, Christina B., et al.
Publicado: (2015)

Early Nuclear Events after Herpesviral Infection
por: Full, Florian, et al.
Publicado: (2019)

CARs—A New Perspective to HCMV Treatment
por: Bednar, Christopher, et al.
Publicado: (2021)

Serum folate levels after UVA exposure: a two-group parallel randomised controlled trial
por: Gambichler, Thilo, et al.
Publicado: (2001)

Role of complement and antibodies in controlling infection with pathogenic simian immunodeficiency virus (SIV) in macaques vaccinated with replication-deficient viral vectors
por: Falkensammer, Barbara, et al.
Publicado: (2009)

Steam Sterilization of Equine Bone Block: Morphological and Collagen Analysis
por: Lo Giudice, R., et al.
Publicado: (2018)

Cannot write session to /tmp/vufind_sessions/sess_jussocaoefrisiksidhkgj665p